Table 2.
PD cohort Metabolic Syndrome components.
| iPD | LRRK2-PD | GBA-PD | significance | |
|---|---|---|---|---|
| # | 104 | 40 | 70 | |
| HDL (mg/Dl) | 56.20 (16.24) | 62.02 (19.36) | 54.24 (16.35) | 0.073 |
| Triglycerides (mg/Dl) | 117.24 (57.96) | 158.10 (100.48) @ | 130.90 (60.60) | 0.015* |
| HbA1c (%) | 5.65 (0.54) | 5.82 (0.51) | 5.61 (0.59) | 0.108 |
| BMI (kg/m2) | 25.58 (3.08) | 25.77 (3.96) | 26.03 (4.16) | 0.725 |
| Hypo-HDL (%) | 20.00% | 7.50% | 20.80% | 0.160 |
| Hypertriglyceridemia (%) | 41.90% | 52.50% | 38.90% | 0.364 |
| Prediabetes (%) | 34.30% | 65.00%@ | 43.10% | 0.004* |
| Hypertension (%) | 75.20% | 80.00% | 79.20% | 0.754 |
| Obesity (BMI > 30) (%) | 9.50% | 15.00% | 19.40% | 0.167 |
iPD – idiopathic Parkinson’s Disease, HDL- High Density Lipoprotein, HbA1c – Hemoglobin A1C, BMI- Body Mass Index. *Significant after correcting for multiple comparisons with Bonferroni adjustment.
@Differences between LRRK2-PD and GBA-PD, iPD.